Bioscope.ai
Bioscope.ai is a physician-founded precision longevity platform that takes the shape of the practice it serves. Whole genomes, labs, advanced panels, imaging, microbiome tests and wearables usually arrive as separate reports. Bioscope.ai considers them as one case. As a result, doctors can see connections that wouldn't be visible one report at a time. Every finding traces to the patient's record and to the published source so the clinician can verify the evidence. Bioscope.ai runs on the doctor's philosophy of medicine. Their protocols, their thresholds and their terminology shape how each patient is seen. It flags areas to investigate, but the doctor determines the plan and presents it. Their method doesn't change. Their reach does.
Average Rating: 4.2/5.0
Total Reviews: 10
Who Is the Company Behind Bioscope.ai?
- Seller: Bioscope.ai
- Company Website:
- Year Founded: 2025
- HQ Location: Carmel, US
-
LinkedIn® Page: www.linkedin.com
53 employees on LinkedIn®
Who Uses This Product?
- Company Size: 70% Small, 40% Medium
What Are Recent G2 Reviews of Bioscope.ai?
"Unified Genomics View With Transparent, Literature-Backed Insights"
Rating: 4.0/5.0 stars
— Vaman G.
"Bioscope.ai Turns Complex Clinical Data Into Clear, Actionable Insights"
Rating: 4.5/5.0 stars
— Kapil S.

